Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Christopher Viehbacher
Age : 61
Public asset : 3,323,816 USD
Country of residence : Unknown
Linked companies : Biogen Inc. - PureTech Health plc

Biography of Christopher Viehbacher 
Chris Viehbacher (born 1960) is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014.

Biography
Early life
Chris Viehbacher was born on March 26, 1960. He graduated from Queen's University in Kingston, Ontario, Canada. He is a certified public accountant, and he speaks French, German and English.

Career
He started his career at PriceWaterhouseCoopers. In 1988, he joined GlaxoSmithKline, where he worked for the next twenty years, including in France for ten years. Until October 29 2014, he served as CEO of Sanofi and Chairman of Genzyme.

He was Chairman of the Pharmaceutical Research and Manufacturers of America from December 2010 to April 2012. He has been Chair of the CEO Roundtable on Cancer since February 2011. He is a member of The Business Roundtable and the International Business Council. He sits on the Board of Directors of Research America and the Burroughs Wellcome Fund. He will serve as President of the European Federation of Pharmaceutical Industries and Associations from June 2013 onwards.

In 2003, he became a Knight in the Legion of Honour. In 2012, he received the Pasteur Foundation Award. He sits on the Board of Visitors of the Fuqua School of Business at Duke University.

Personal life
He is married and has three children.



Source @ Wikipedia


Current positions of Christopher Viehbacher 
Holdings of Christopher Viehbacher 
Christopher Viehbacher : Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/26LVMH's Arnault brushes off succession question
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/19Ark's Wood remains bullish on Tesla, says oil stock rally 'defying logic'
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
01/19JPMorgan CEO Dimon sees interest rates going beyond 5% - CNBC
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
01/19Sacked GM workers in India sue company, CEO Barra for unpaid compensation
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
01/26Wells Fargo CEO Scharf's 2022 pay unchanged at $24.5 million
RE
More news


© 2023 People and Ownership :   
Christopher Viehbacher : Connections 


Latest news about Christopher Viehbacher 
01/09Transcript : Biogen Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 11:15 AM
CI
01/05Biogen splits R&D division ahead of key decision on Alzheimer's drug
RE
2022PureTech Health plc Announces Executive Changes
CI
2022Biogen Inc., Sage Therapeutics, Inc. - Special Call
CI
2022Health Care Up After AztraZeneca Earnings -- Health Care Roundup
DJ
2022Biogen Names Christopher Viehbacher CEO
MT
2022Biogen hires former Sanofi head Viehbacher as CEO
RE
More news